Weight Loss NP
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
Arvada, CO
Arvada sits just northwest of Denver on the Front Range at roughly 5,344 feet, where dry Colorado air and sun exposure make dehydration a year-round reality. Olde Town Arvada has become a dense wellness corridor in the last five years, with drip bars, functional medicine practices, and med spas clustered along Grandview Avenue and Wadsworth Boulevard. Many clinics serve a mixed clientele of Coors Brewery employees, Jefferson County first responders, and Leyden-area cyclists recovering from North Table Mountain rides. Colorado's Board of Nursing authorizes RNs to start peripheral IVs under standing orders from a medical director, and Arvada providers generally partner with nurse practitioners who hold full prescriptive authority under state NP rules. Local interest in mold recovery and glutathione drips has grown sharply given Colorado's aging housing stock and post-flood remediation cases from the 2013 floods that still surface clinically.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Colorado medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.